ArthVani
mutual-funds

Helios Mutual Fund Pivot: Mid and Small-caps Preferred Over 'Expensive' Large-caps

By Arth Vani Desk · 2026-06-10

Helios Mutual Fund is reallocating capital away from large-cap stocks toward mid and small-cap companies due to superior earnings growth. The fund has recently added high-growth names like Adani Enterprises and Dixon Technologies while avoiding sectors like metals.

Key takeaways

Helios Mutual Fund is reallocating capital away from large-cap stocks toward mid and small-cap companies due to superior earnings growth. The fund has recently added high-growth names like Adani Enterprises and Dixon Technologies while avoiding sectors like metals.

Growth Momentum Shifts Away from Large-caps

Indian equity markets are witnessing a strategic reallocation of capital as fund managers prioritize growth potential over traditional safety nets. Dinshaw Irani of Helios Mutual Fund has indicated a clear shift in investment preference, moving away from large-cap companies in favor of mid and small-cap stocks. This decision is primarily driven by the Price-to-Earnings-to-Growth (PEG) ratio, which suggests that large-cap stocks are currently trading at valuations that do not align with their slower growth rates.

The Valuation Gap

According to the fund's assessment, large-cap companies are appearing increasingly 'expensive' when measured against their earnings trajectory. In contrast, mid and small-cap companies are demonstrating significantly higher growth trends. For retail investors, this signifies a period where 'quality' is being redefined by a company's ability to scale quickly rather than just its market capitalization size.

New Portfolio Additions

In line with this strategy, Helios Mutual Fund has introduced several aggressive growth stocks into its portfolio. Key additions include:

Sectors to Avoid

While the fund is bullish on domestic growth stories, it remains cautious about certain sectors. Helios is currently avoiding the metals sector, which is often sensitive to global commodity cycles and volatile pricing. Additionally, the fund is steering clear of US-facing pharmaceutical companies, likely due to regulatory hurdles and pricing pressures in the American market. This suggests a preference for businesses with strong domestic tailwinds or specific technological moats.

Implications for Retail Investors

The move by Helios reflects a broader sentiment among institutional players who are looking for 'alpha'—returns that beat the broader market index. As large-caps face valuation hurdles, the mid-cap and small-cap segments are becoming the primary engines for portfolio growth, provided investors can stomach the higher volatility associated with these smaller players.

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. This content is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell specific stocks.

Source: Economictimes
Investments are subject to market risks. This article is for informational purposes only and not financial advice.